文献检索/Pharmacoepidemiology and Drug SafetyEM-T3Pharmacoepidemiology and Drug Safety2020-11-04第 29 卷第 12 期，1532-1539高影响力 · 前 10%The utility of real‐world evidence for benefit‐risk assessment, communication, and evaluation of pharmaceuticals: Case studiesChristine RadawskiEli Lilly (United States)Tarek A. HammadSusan ColillaTeva Pharmaceuticals (United States)PAUL M. COPLANJohnson & Johnson (United States)Kenneth HornbuckleEli Lilly (United States)Emily FreemanLundbeck (United States)Meredith Y. SmithUniversity of Southern CaliforniaRachel E. SobelPriya BahriEuropean Medicines AgencyAriel E. AriasHealth CanadaDimitri BennettUniversity of Pennsylvania去出版社页面 引用论文图谱收藏 被引提醒分享打印登录后看摘要和中文要点英文摘要、AI 生成的中文摘要和三条要点、参考文献和引证文献列表、论文图谱，注册免费。登录 / 注册关键词real-world evidencerisk-benefit assessmentrisk-benefit communicationrisk minimizationdrug regulationregulatory decision-makinghealth technology assessmentpatient accessdigital health datastakeholder engagement参考文献24引证文献3相似文献引文网络关联作者相关机构登录后可以看完整列表。去登录论文图谱本篇和它的参考文献、引证文献、相似文献登录后可以看这篇的论文图谱：谁被它引用、谁引用了它、还有哪些相似的研究。登录 / 注册
